BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

610 related articles for article (PubMed ID: 15781474)

  • 1. TGF-{beta}1 activates two distinct type I receptors in neurons: implications for neuronal NF-{kappa}B signaling.
    König HG; Kögel D; Rami A; Prehn JH
    J Cell Biol; 2005 Mar; 168(7):1077-86. PubMed ID: 15781474
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Balancing the activation state of the endothelium via two distinct TGF-beta type I receptors.
    Goumans MJ; Valdimarsdottir G; Itoh S; Rosendahl A; Sideras P; ten Dijke P
    EMBO J; 2002 Apr; 21(7):1743-53. PubMed ID: 11927558
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of Smad proteins in the regulation of NF-kappaB by TGF-beta in colon cancer cells.
    Grau AM; Datta PK; Zi J; Halder SK; Beauchamp RD
    Cell Signal; 2006 Jul; 18(7):1041-50. PubMed ID: 16288847
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ALK1 opposes ALK5/Smad3 signaling and expression of extracellular matrix components in human chondrocytes.
    Finnson KW; Parker WL; ten Dijke P; Thorikay M; Philip A
    J Bone Miner Res; 2008 Jun; 23(6):896-906. PubMed ID: 18333754
    [TBL] [Abstract][Full Text] [Related]  

  • 5. ALK5 and Smad4 are involved in TGF-beta1-induced pulmonary endothelial permeability.
    Birukova AA; Adyshev D; Gorshkov B; Birukov KG; Verin AD
    FEBS Lett; 2005 Jul; 579(18):4031-7. PubMed ID: 16004987
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Targeting endogenous transforming growth factor beta receptor signaling in SMAD4-deficient human pancreatic carcinoma cells inhibits their invasive phenotype1.
    Subramanian G; Schwarz RE; Higgins L; McEnroe G; Chakravarty S; Dugar S; Reiss M
    Cancer Res; 2004 Aug; 64(15):5200-11. PubMed ID: 15289325
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Balance of pro-apoptotic transforming growth factor-beta and anti-apoptotic insulin effects in the control of cell death in the postnatal mouse retina.
    Duenker N; Valenciano AI; Franke A; Hernández-Sánchez C; Dressel R; Behrendt M; De Pablo F; Krieglstein K; de la Rosa EJ
    Eur J Neurosci; 2005 Jul; 22(1):28-38. PubMed ID: 16029193
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Dissecting the role of TGF-beta type I receptor/ALK5 in pancreatic ductal adenocarcinoma: Smad activation is crucial for both the tumor suppressive and prometastatic function.
    Schniewind B; Groth S; Sebens Müerköster S; Sipos B; Schäfer H; Kalthoff H; Fändrich F; Ungefroren H
    Oncogene; 2007 Jul; 26(33):4850-62. PubMed ID: 17297450
    [TBL] [Abstract][Full Text] [Related]  

  • 9. SB-505124 is a selective inhibitor of transforming growth factor-beta type I receptors ALK4, ALK5, and ALK7.
    DaCosta Byfield S; Major C; Laping NJ; Roberts AB
    Mol Pharmacol; 2004 Mar; 65(3):744-52. PubMed ID: 14978253
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Distinct regulation of gene expression in human endothelial cells by TGF-beta and its receptors.
    Wu X; Ma J; Han JD; Wang N; Chen YG
    Microvasc Res; 2006 Jan; 71(1):12-9. PubMed ID: 16405919
    [TBL] [Abstract][Full Text] [Related]  

  • 11. SPARC regulates TGF-beta1-dependent signaling in primary glomerular mesangial cells.
    Francki A; McClure TD; Brekken RA; Motamed K; Murri C; Wang T; Sage EH
    J Cell Biochem; 2004 Apr; 91(5):915-25. PubMed ID: 15034927
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Gene expression profiling demonstrates that TGF-beta1 signals exclusively through receptor complexes involving Alk5 and identifies targets of TGF-beta signaling.
    Karlsson G; Liu Y; Larsson J; Goumans MJ; Lee JS; Thorgeirsson SS; Ringnér M; Karlsson S
    Physiol Genomics; 2005 May; 21(3):396-403. PubMed ID: 15769904
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel mechanism by which hepatocyte growth factor blocks tubular epithelial to mesenchymal transition.
    Yang J; Dai C; Liu Y
    J Am Soc Nephrol; 2005 Jan; 16(1):68-78. PubMed ID: 15537870
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nuclear factor-kappaB/Rel blocks transforming growth factor beta1-induced apoptosis of murine hepatocyte cell lines.
    Arsura M; FitzGerald MJ; Fausto N; Sonenshein GE
    Cell Growth Differ; 1997 Oct; 8(10):1049-59. PubMed ID: 9342183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Transforming growth factor-beta 1 (TGF-beta1) promotes IL-2 mRNA expression through the up-regulation of NF-kappaB, AP-1 and NF-AT in EL4 cells.
    Han SH; Yea SS; Jeon YJ; Yang KH; Kaminski NE
    J Pharmacol Exp Ther; 1998 Dec; 287(3):1105-12. PubMed ID: 9864299
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mutant p53 attenuates the SMAD-dependent transforming growth factor beta1 (TGF-beta1) signaling pathway by repressing the expression of TGF-beta receptor type II.
    Kalo E; Buganim Y; Shapira KE; Besserglick H; Goldfinger N; Weisz L; Stambolsky P; Henis YI; Rotter V
    Mol Cell Biol; 2007 Dec; 27(23):8228-42. PubMed ID: 17875924
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Apoptosis of mink lung epithelial cells by co-treatment of low-dose staurosporine and transforming growth factor-beta1 depends on the enhanced TGF-beta signaling and requires the decreased phosphorylation of PKB/Akt.
    Ju EM; Choi KC; Hong SH; Lee CH; Kim BC; Kim SJ; Kim IH; Park SH
    Biochem Biophys Res Commun; 2005 Mar; 328(4):1170-81. PubMed ID: 15708000
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SMAD pathway mediation of BDNF and TGF beta 2 regulation of proliferation and differentiation of hippocampal granule neurons.
    Lu J; Wu Y; Sousa N; Almeida OF
    Development; 2005 Jul; 132(14):3231-42. PubMed ID: 15958511
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces expression of vascular endothelial growth factor in human retinal pigment epithelial cells: involvement of mitogen-activated protein kinases.
    Nagineni CN; Samuel W; Nagineni S; Pardhasaradhi K; Wiggert B; Detrick B; Hooks JJ
    J Cell Physiol; 2003 Dec; 197(3):453-62. PubMed ID: 14566975
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Blocking Smad7 restores TGF-beta1 signaling in chronic inflammatory bowel disease.
    Monteleone G; Kumberova A; Croft NM; McKenzie C; Steer HW; MacDonald TT
    J Clin Invest; 2001 Aug; 108(4):601-9. PubMed ID: 11518734
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 31.